" class="no-js "lang="en-US"> Bayer Archives - Medtech Alert
Friday, March 01, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Technology From Acuitas Therapeutics

Bayer AG is joining forces with Acuitas Therapeutics, a biotechnology company specializing in the development […]

Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology

Bayer and Bicycle Therapeutics, a biotechnology company pioneering a new and differentiated class of therapeutics […]

Telix to Supply Bayer with Illuccix® for Global Phase III Prostate Cancer Study

Telix Pharmaceuticals today announces that it has entered into an agreement with Bayer AG (Bayer) […]

Bayer Expands Global Clinical Program for NUBEQA® (darolutamide) in Prostate Cancer

Bayer further expands the global clinical development program for NUBEQA (darolutamide) in prostate cancer. The […]

Bayer’s Bluerock Therapeutics Establishes European Site for Cell Therapy Innovation

Bayer AG announced today that BlueRock Therapeutics LP (BlueRock), a clinical stage biopharmaceutical company and […]

Illumina Introduces New Pan-Cancer Companion Diagnostic to Match Patients with Rare Genetic Mutations to Targeted Therapy

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the […]

Bayer Announces Changes in Executive Leadership Team of Crop Science Division

Bayer today announced changes in the leadership team of its Crop Science division, with Kelly […]

Leaps by Bayer Leads $80M Series A Financing for Cellino Biotech to Autonomize Stem Cell Therapy Manufacturing

Cellino Biotech, Inc., an autonomous cell therapy manufacturing company, today announced the completion of a […]

Bayer Announces Christoph Koenen as New Global Head of Clinical Development and Operations within Pharmaceuticals Research and Development at Bayer

Bayer today announced Christoph Koenen as the new Global Head of Clinical Development and Operations […]

Bayer to Invest Over €400 Million to Increase Access to Modern Contraception

Bayer today announced to invest over €400 million, reinforcing its commitment to providing 100 million […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more